This company has been acquired
Science 37 Holdings Future Growth
Future criteria checks 1/6
Science 37 Holdings is forecast to grow earnings and revenue by 66.7% and 17.5% per annum respectively while EPS is expected to grow by 67.9% per annum.
Key information
66.7%
Earnings growth rate
67.9%
EPS growth rate
| Life Sciences earnings growth | 17.7% |
| Revenue growth rate | 17.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 30 Jan 2024 |
Recent future growth updates
Recent updates
Science 37 Holdings, Inc. (NASDAQ:SNCE) Might Not Be As Mispriced As It Looks
Dec 18
Investors Continue Waiting On Sidelines For Science 37 Holdings, Inc. (NASDAQ:SNCE)
Apr 17Science 37, Syapse team for faster patient enrollment in cancer trials
Aug 18Science 37 reports Q2 mixed earnings; narrows FY22 guidance
Aug 11Results: Science 37 Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
May 13Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans
Apr 11Science 37: Pioneering Decentralized Clinical Trials
Jan 02We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth
Nov 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 95 | 3 | -18 | 30 | 3 |
| 12/31/2025 | 75 | -25 | -28 | 3 | 3 |
| 12/31/2024 | 63 | -38 | -44 | -9 | 4 |
| 12/31/2023 | 58 | -73 | -81 | -46 | 4 |
| 9/30/2023 | 60 | -125 | -74 | -48 | N/A |
| 6/30/2023 | 62 | -134 | -84 | -58 | N/A |
| 3/31/2023 | 66 | -121 | -98 | -67 | N/A |
| 12/31/2022 | 70 | -51 | -107 | -75 | N/A |
| 9/30/2022 | 75 | -50 | -115 | -82 | N/A |
| 6/30/2022 | 73 | -41 | -108 | -78 | N/A |
| 3/31/2022 | 66 | -43 | -83 | -57 | N/A |
| 12/31/2021 | 60 | -94 | -57 | -36 | N/A |
| 9/30/2021 | 50 | -42 | -37 | -23 | N/A |
| 6/30/2021 | 43 | -35 | -33 | -23 | N/A |
| 3/31/2021 | 33 | -33 | -33 | -26 | N/A |
| 12/31/2020 | 24 | -32 | -32 | -25 | N/A |
| 12/31/2019 | 14 | -18 | -20 | -16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SNCE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SNCE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SNCE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SNCE's revenue (17.5% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: SNCE's revenue (17.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SNCE's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/03/11 13:59 |
| End of Day Share Price | 2024/03/11 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Science 37 Holdings, Inc. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eric Coldwell | Baird |
| Matthew Hewitt | Craig-Hallum Capital Group LLC |
| Frank Takkinen | Lake Street Capital Markets, LLC |